Yamamoto R - Search Results

1

[Treatment of ovarian cancer with pelvic and paraaortic lymph node metastasis].

Ebina Y, Yamamoto R, Sakuragi N. Ebina Y, et al. Among authors: yamamoto r. Nihon Rinsho. 2004 Oct;62 Suppl 10:565-9. Nihon Rinsho. 2004. PMID: 15535309 Review. Japanese. No abstract available.

2

Para-aortic lymph node metastasis in relation to serum CA 125 levels and nuclear grade in endometrial carcinoma.

Ebina Y, Sakuragi N, Hareyama H, Todo Y, Nomura E, Takeda M, Okamoto K, Yamada H, Yamamoto R, Fujimoto S. Ebina Y, et al. Among authors: yamamoto r. Acta Obstet Gynecol Scand. 2002 May;81(5):458-65. doi: 10.1034/j.1600-0412.2002.810514.x. Acta Obstet Gynecol Scand. 2002. PMID: 12027821 Free article.

3

Combined use of magnetic resonance imaging, CA 125 assay, histologic type, and histologic grade in the prediction of lymph node metastasis in endometrial carcinoma.

Todo Y, Sakuragi N, Nishida R, Yamada T, Ebina Y, Yamamoto R, Fujimoto S. Todo Y, et al. Among authors: yamamoto r. Am J Obstet Gynecol. 2003 May;188(5):1265-72. doi: 10.1067/mob.2003.318. Am J Obstet Gynecol. 2003. PMID: 12748496

4

Lymphatic mapping and sentinel node identification as related to the primary sites of lymph node metastasis in early stage ovarian cancer.

Negishi H, Takeda M, Fujimoto T, Todo Y, Ebina Y, Watari H, Yamamoto R, Minakami H, Sakuragi N. Negishi H, et al. Among authors: yamamoto r. Gynecol Oncol. 2004 Jul;94(1):161-6. doi: 10.1016/j.ygyno.2004.04.023. Gynecol Oncol. 2004. PMID: 15262135

5

[Chemotherapy for high-risk cervical carcinoma].

Yamamoto R, Sakuragi N, Okamoto K. Yamamoto R, et al. Nihon Rinsho. 2004 Oct;62 Suppl 10:169-74. Nihon Rinsho. 2004. PMID: 15535227 Review. Japanese. No abstract available.

6

Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer.

Watari H, Todo Y, Takeda M, Ebina Y, Yamamoto R, Sakuragi N. Watari H, et al. Among authors: yamamoto r. Gynecol Oncol. 2005 Mar;96(3):651-7. doi: 10.1016/j.ygyno.2004.11.026. Gynecol Oncol. 2005. PMID: 15721407

7

Comparison of the results of radical hysterectomy: sequential observations in each period.

Kobamatsu Y, Yamamoto R, Kaneuchi M, Mitamura T, Minobe S, Todo Y, Takeda M, Okamoto K, Nomura E, Negishi H, Sakuragi N, Fujimoto S. Kobamatsu Y, et al. Among authors: yamamoto r. Jpn J Clin Oncol. 2002 Mar;32(3):103-7. doi: 10.1093/jjco/hyf024. Jpn J Clin Oncol. 2002. PMID: 11956305

8

Preoperative serum SCC, CA125, and CA19-9 levels and lymph node status in squamous cell carcinoma of the uterine cervix.

Takeda M, Sakuragi N, Okamoto K, Todo Y, Minobe S, Nomura E, Negishi H, Oikawa M, Yamamoto R, Fujimoto S. Takeda M, et al. Among authors: yamamoto r. Acta Obstet Gynecol Scand. 2002 May;81(5):451-7. doi: 10.1034/j.1600-0412.2002.810513.x. Acta Obstet Gynecol Scand. 2002. PMID: 12027820 Free article.

9

A phase I/II study of carboplatin and paclitaxel in patients with epithelial ovarian cancer.

Yamamoto R, Minobe S, Kaneuchi M, Sakuragi N, Fujimoto S, Ishizaki Y, Domon H, Hareyama H, Sato C, Fujino T, Kawaguchi I, Yamaguchi T, Fujimoto T, Yoshiaki K. Yamamoto R, et al. Jpn J Clin Oncol. 2002 Apr;32(4):128-34. Jpn J Clin Oncol. 2002. PMID: 12072422 Clinical Trial.

10

Clinical trial and pharmacokinetic study of combination paclitaxel and carboplatin in patients with epithelial ovarian cancer.

Yamamoto R, Kaneuchi M, Nishiya M, Todo Y, Takeda M, Okamoto K, Negishi H, Sakuragi N, Fujimoto S, Hirano T. Yamamoto R, et al. Cancer Chemother Pharmacol. 2002 Aug;50(2):137-42. doi: 10.1007/s00280-002-0471-1. Epub 2002 Jun 15. Cancer Chemother Pharmacol. 2002. PMID: 12172979 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,271 results

Search Page

Filters